Lactobacillus gasseri SBT2055

What is Lactobacillus gasseri SBT2055?

Scientific name: Lactobacillus paragasseri  SBT2055 
(previously classified as Lactobacillus gasseri  SBT2055)

Megmilk Snow Brand has invested decades researching Lactic Acid Bacteria and discovered health benefits with “L. gasseri SBT2055" (Megmilk Snow Brand’s proprietary)

The Probiotic strain, L. gasseri SBT2055, was discovered in the 1990s. It has been confirmed to live in the human intestines for a long time offering many health benefits.  L. gasseri SBT2055 substantiate this claim by demonstrating proven clinical effects to - “reduce visceral fat accumulation”, through various safety and efficacy studies.

Discovery of Lactobacillus gasseri SBT2055

SBT2055, was identified during research on L.actobacillus gasseri strains. The research began focusing on flavour characteristics and resistance to stomach acid to ensure that the probiotics enter the intestines alive and provide various health benefits. 

  • In 2001, the Strain’s prolonged presence in the human gut was proven. 
  • In a study published in 2010, the first human trials conducted confirmed that SBT2055 has the effect of reducing visceral fat.
  • In addition to preventing the accumulation of visceral fat, SBT2055 also has other benefits, including anti-inflammatory properties against gingivitis and prevention of infections against influenza viruses. This strain eventually became a key ingredient of Megmilk Snow Brand’s products.

L. gasseri SBT 2055: supports [or contributes to]- “Reduce visceral fat” 

What is Visceral Fat?

Body fat is the general term for subcutaneous fat and visceral fat. Subcutaneous fat refers to the fat that accumulates in the subcutaneous tissue under the skin.   

Visceral fat refers to fat that accumulates around the organs in the abdomen. Since fat adheres to the membranes around the stomach and intestines, the accumulation of visceral fat leads to a protruding stomach. Visceral fat is characterized for its ease of accumulation as well as for being easy to eliminate. ​

The excessive accumulation of visceral fat is a cause of high blood pressure, high blood glucose, and metabolic syndrome. 

  History of Lactobacillus gasseri SBT2055

1990:

L. gasseri SBT2055 - Discovery

2001:

Confirmed to persist in the intestines for a long time

2002:

First use in Megmilk Snow Brand product in Japan

       

2010:

Yogurt containing SBT2055 confirmed to reduce visceral fat volume (clinical trials)

2015:

Clinical trials demonstrate that the suppression of fat absorption by SBT2055 is linked to its ability to suppress the accumulation of visceral fat

2018:

Launched yogurt product as a FOSHU: "Helps reduce visceral fat"

       

Received the following awards for research related to SBT2055 
-The Japanese Society of Nutrition and Food Science Technology Award 
-IDF World Dairy Summit 2018 Poster Award Outstanding (Silver Award) 
-Food and Immunology Industry Award

2019:

Received the '2018 Tojuro Iijima Food Technology Award' for research related to SBT2055

2020:

Launched a capsule product with a Food with Function Claim "Reduces Visceral Fat"

       

Benefits of Lactobacillus gasseri SBT2055

Prevention of Visceral Fat Accumulation:

Suppression of lipid (fat) absorption by inhibiting fat breakdown and promotes fat excretion*

Improve Gut Health

Supports healthy gut microbiome contributing to immune system*

 

 
Possible Commercial Applications:

L. gasseri SBT2055 is a value-added product offering numerous benefits for gut health. It can be added to several foods intended to promote gut health, weight management, and reduce visceral fat.

  • Foods:

Yogurts, Ice creams
  • Drinks:

Beverages or milk beverages
  • Supplements:

Capsules (Listed and complimentary medicines)

 
 
Product Information:

Product Format:

Powder form

Strain Type:

Live Bacteria

Storage Conditions:

Chilled

Shelf Life:

548 days from manufacturing date

Regulatory Information:

Japan - Foods using SBT2055 are approved as Foods with Function claims and Foods for Specified Health Uses (FOSHU) ​

Australia - Non-novel (FSANZ)

Research Publications:

For further research information, please visit – Click Here

For product information, please contact us at marketing@snowbrand.com.au
   
 

References:

  • Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects
    A. Ogawa et al.
    Lipids in Health and Disease (2015) 14:20
  • Milk Fermented with Yogurt Cultures and Lactobacillus gasseri SBT2055 (LG2055: strain Yukijirushi) Compared with Yogurt: Influence on Intestinal Microflora and Bowel Habits of Healthy Young Women.
    Ishida Y. et al.
    Pharmacometrics Vol.61(2/3) pp. 203-213 2001